FIELD: medicine. SUBSTANCE: method involves examining blood to determine T- lymphocyte number and patient HLA-phenotype. HLA B5 of haplotype A2B13 is detected and HLA B12 and CW5 are absent in patient genotype and absolute number of T-lymphocytes being in an interval of 0.7 x 0,7•109/l to 1.1 x 109/l, positive effectiveness of low frequency magnetotherapy is predicted. EFFECT: enhanced effectiveness of treatment. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF FORECASTING FAST PROGRESSION OF DISEASE IN PATIENTS SUFFERING FROM CHRONIC HEPATITIS C | 2007 |
|
RU2354975C1 |
| METHOD OF TREATMENT OF ACUTE VIRAL HEPATITIS B | 2001 |
|
RU2207135C2 |
| METHOD FOR PREDICTION OF CLINICAL OUTCOMES OF ANTIVIRAL THERAPY OF CHRONIC HEPATITIS B | 2011 |
|
RU2469327C1 |
| METHOD FOR PREDICTING THE RESULT OF ACUTE VIRAL HEPATITIS B | 2006 |
|
RU2315308C1 |
| METHOD OF NON-INVASIVE DETERMINATION OF LIVER ACIDITY IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2468744C1 |
| METHOD OF PREDICTING INTERFERON-RIVABIRIN-INDUCED NEUROPENIA IN PATIENTS WITH CHRONIC HEPATITIS C OBTAINING COMBINED ANTIVIRAL THERAPY | 2011 |
|
RU2444998C1 |
| METHOD FOR PREDICTING RAPID DISEASE PROGRESS IN HIV-INFECTED PATIENTS | 2006 |
|
RU2306566C1 |
| METHOD FOR FAST ASSESSMENT OF DEGREE OF ACTIVITY OF CHRONIC HEPATITIS IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2469326C1 |
| METHOD OF PROGNOSIS OF CHRONIC HEPATITIS B COURSE SPECIFICITY IN PATIENTS WITH HEMOBLASTOSIS | 2001 |
|
RU2200954C2 |
| METHOD FOR PREDICTION OF RISK OF ARTERIAL HYPERTENSION DEVELOPMENT AND PROGRESS IN PATIENTS WITH CHRONIC HEPATITIS AT ANTI-VIRAL THERAPY BACKGROUND | 2016 |
|
RU2623793C2 |
